KEGG: hso:HS_0596
STRING: 205914.HS_0596
Haemophilus somnus UPF0283 membrane protein HS_0596 (also referred to as HS_0596) is a 357-amino acid membrane protein encoded by the HS_0596 gene in Histophilus somni (formerly known as Haemophilus somnus). This protein belongs to the UPF0283 protein family and is of particular interest because it is expressed in a bacterial pathogen responsible for causing various bovine diseases, including thrombotic meningoencephalitis, respiratory diseases, septicemia, abortion, arthritis, and myocarditis .
The significance of this protein lies in understanding its potential role in H. somni pathogenesis and host-pathogen interactions. Research on HS_0596 contributes to our knowledge of bacterial membrane proteins in general, and specifically to understanding virulence mechanisms in H. somni infections .
Recombinant HS_0596 protein is typically produced using E. coli expression systems. The full-length sequence (amino acids 1-357) is cloned into an expression vector with an N-terminal His-tag to facilitate purification. The expression construct is then transformed into E. coli, where the protein is expressed under controlled conditions .
After expression, the protein is purified using affinity chromatography techniques that utilize the His-tag. The purified protein is then typically lyophilized for stability and storage. For research applications, the lyophilized protein can be reconstituted in an appropriate buffer (often Tris/PBS-based buffer with 6% Trehalose, pH 8.0) to a concentration of 0.1-1.0 mg/mL .
The addition of 5-50% glycerol is recommended for long-term storage, with a final concentration of 50% glycerol being commonly used. Properly prepared, the protein can be stored at -20°C or -80°C, with care taken to avoid repeated freeze-thaw cycles .
The role of HS_0596 in H. somni virulence is not fully characterized, but several lines of evidence suggest potential contributions to pathogenesis. H. somni is known to undergo antigenic and structural phase variation in its lipooligosaccharide (LOS), which contributes to immune evasion and virulence . While HS_0596 itself is not directly implicated in LOS biosynthesis, it may function within membrane complexes that support bacterial adaptation during infection.
H. somni causes vascular inflammation leading to thrombotic meningoencephalitis (TME) and activates bovine platelets, which subsequently induce endothelial cell pro-inflammatory responses. This process involves the expression of adhesion molecules (ICAM-1, E-selectin), tissue factor, and cytokines (IL-1β, MCP-1, MIP-1α) . As a membrane protein, HS_0596 may participate in host-pathogen interactions that trigger these inflammatory cascades.
H. somni's virulence factors include:
Ability to form biofilms
Acquisition of iron as a nutrient
Binding of host immunoglobulins through outer membrane proteins (OMPs)
Genetic variability in surface antigens
Phase variation capabilities
While direct evidence linking HS_0596 to these mechanisms is limited, its membrane localization makes it a candidate for involvement in one or more of these processes .
Several complementary approaches can be employed to study protein-protein interactions involving HS_0596:
A comprehensive approach would employ multiple methods to cross-validate interactions and distinguish between direct and indirect associations .
Specific resistance rates in respiratory isolates include:
Oxytetracycline: 28.3%
Kanamycin: 24.5%
Ampicillin: 24.5%
Amoxicillin: 13.2%
Nalidixic acid: 1.9%
Danofloxacin: 1.9%
Regarding resistance mechanisms, several antimicrobial resistance genes have been identified in H. somni:
blaROB-1: Associated with resistance to ampicillin and amoxicillin
aphA-1: Associated with kanamycin resistance
tetH/tetR: Associated with oxytetracycline resistance
strA/strB: Associated with streptomycin resistance
While HS_0596 has not been directly implicated in antimicrobial resistance, as a membrane protein, it could potentially contribute to membrane permeability or efflux systems that affect drug entry or extrusion. Additionally, membrane proteins can be part of stress response systems that help bacteria survive antimicrobial exposure .
The distribution of antimicrobial resistance genes in H. somni appears to be associated with specific genetic lineages, suggesting that resistance determinants may spread via integrative and conjugative elements (ICEs) within certain bacterial populations .
Designing functional studies for recombinant HS_0596 requires careful consideration of protein stability, solubility, and biological activity. Based on available data and general principles for membrane protein research, the following experimental conditions are recommended:
Buffer Composition:
Base buffer: Tris/PBS-based buffer, pH 8.0
Stabilizers: 6% Trehalose
For long-term storage: 50% glycerol (final concentration)
Temperature Considerations:
Storage temperature: -20°C to -80°C for stock solutions
Working aliquots: 4°C for up to one week
Experimental temperature: 25-37°C (depending on specific assay)
Reconstitution Protocol:
Centrifuge the vial before opening to bring contents to the bottom
Reconstitute in deionized sterile water to 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% for storage
Prepare small aliquots to avoid repeated freeze-thaw cycles
Experimental Considerations:
For membrane protein functional studies, consider incorporating HS_0596 into liposomes or nanodiscs to maintain native-like membrane environment
For interaction studies, ensure that the His-tag does not interfere with potential binding domains; if necessary, include a control with the tag cleaved
Include appropriate positive and negative controls specific to the functional assay being performed
A comprehensive experimental design to investigate HS_0596's role in H. somni pathogenesis should incorporate multiple approaches:
1. Genetic Manipulation Approach:
Generate HS_0596 knockout mutants using homologous recombination or CRISPR-Cas techniques
Create complemented strains to verify phenotypes
Develop strains with tagged HS_0596 for localization studies
2. In Vitro Infection Models:
Compare wild-type and HS_0596 mutant strains in:
Adhesion assays with bovine endothelial cells
Invasion assays with relevant host cells
Biofilm formation assays
Resistance to serum killing
Resistance to phagocytosis
3. Ex Vivo Studies:
Evaluate interactions with bovine immune cells and platelets
Assess cytokine induction profiles
Examine effects on endothelial cell activation
4. In Vivo Studies:
Use appropriate animal models (preferably bovine) to compare:
Colonization efficiency
Disease progression
Inflammatory responses
Tissue tropism
5. Molecular Interaction Studies:
Identify host receptors or targets using pull-down assays
Confirm interactions using techniques like surface plasmon resonance
Characterize binding domains through mutational analysis
This experimental design follows standard approaches in experimental research, including proper controls, variable definition, and hypothesis testing .
| Experimental Approach | Key Variables to Control | Expected Outcomes |
|---|---|---|
| Genetic Manipulation | Growth conditions, expression levels | Phenotypic changes related to virulence |
| In Vitro Models | Cell passage number, multiplicity of infection | Differences in adhesion, invasion, or survival |
| Ex Vivo Studies | Blood donor variability, incubation time | Altered immune activation profiles |
| In Vivo Studies | Animal age, inoculation dose, route | Changes in disease progression or bacterial load |
| Molecular Studies | Protein purity, buffer conditions | Identification of specific interaction partners |
Independent Variables:
Concentration of recombinant HS_0596
Experimental conditions (temperature, pH, buffer composition)
Presence of potential interacting molecules
Duration of exposure/incubation
Dependent Variables:
Protein binding/interaction measurements
Cellular responses (e.g., cytokine production, adhesion molecule expression)
Functional outcomes specific to experimental hypothesis
Control Groups:
Negative Controls:
Buffer-only treatments
Irrelevant recombinant protein of similar size/structure
Heat-denatured HS_0596 protein
Positive Controls:
Known stimulus that induces the expected response
Well-characterized protein with similar function (if available)
Additional Controls:
His-tag only protein to control for tag effects
Endotoxin control to ensure observed effects are not due to LPS contamination
Experimental Design Considerations:
Use randomization to assign treatments
Include technical and biological replicates
Consider blinding during data analysis when possible
Calculate appropriate sample sizes based on expected effect sizes
Control for batch effects in protein preparation
Potential Confounding Variables:
Endotoxin contamination during protein preparation
Protein aggregation or misfolding
Buffer components that may affect the system under study
Variation in cell culture conditions or animal models
This approach aligns with best practices in experimental design as outlined in the search results, particularly the need to clearly define variables, control for confounding factors, and include appropriate controls to validate findings .
Expression and purification of membrane proteins like HS_0596 present several technical challenges. Based on general principles of membrane protein biochemistry and specific information about HS_0596, these challenges and their solutions include:
Solution: Optimize codon usage for the expression host; consider using specialized E. coli strains designed for membrane protein expression such as C41(DE3) or C43(DE3).
Approach: Test different promoter strengths and induction conditions (temperature, inducer concentration, duration).
Solution: Lower induction temperature (16-20°C), reduce inducer concentration, or use fusion partners that enhance solubility (e.g., MBP, SUMO).
Approach: If inclusion bodies form, develop a refolding protocol or switch to a membrane-based extraction approach.
Solution: Use stabilizing additives in buffers (e.g., glycerol, specific lipids, trehalose).
Approach: Minimize exposure to detergents by optimizing extraction conditions and purification speed.
Solution: Use size exclusion chromatography as a final purification step to isolate homogeneous protein populations.
Approach: Verify protein quality by SDS-PAGE, western blotting, and mass spectrometry.
Solution: Consider reconstitution into nanodiscs, liposomes, or amphipols after purification.
Approach: Verify proper folding using circular dichroism or limited proteolysis.
Recommended Purification Protocol:
Express in E. coli with optimized conditions (16-20°C, 0.1-0.5 mM IPTG)
Extract membrane fraction using differential centrifugation
Solubilize membranes using mild detergents (DDM, LMNG, or digitonin)
Purify using Ni-NTA affinity chromatography with imidazole gradient elution
Apply size exclusion chromatography for final purification
Consider reconstitution into membrane mimetics for functional studies
This approach incorporates best practices for membrane protein purification while addressing the specific properties of HS_0596 .
Studying membrane protein interactions presents unique challenges due to the hydrophobic nature of these proteins and their native lipid environment. Several strategies can overcome these difficulties:
Solution: Use membrane mimetics such as nanodiscs, liposomes, or styrene-maleic acid lipid particles (SMALPs) that preserve the lipid environment.
Approach: Compare results across different membrane mimetic systems to ensure consistency.
Solution: Include appropriate detergents or lipids in binding buffers and increase stringency in washing steps.
Approach: Use crosslinking approaches that capture specific interactions before extraction from membranes.
Solution: Employ amplification techniques such as proximity ligation assays or utilize highly sensitive detection methods like fluorescence resonance energy transfer (FRET).
Approach: Design experiments with appropriate controls to distinguish specific from non-specific signals.
Solution: Use techniques that detect direct interactions such as crosslinking mass spectrometry or biolayer interferometry with purified components.
Approach: Validate interactions using multiple independent techniques.
Recommended Approaches for HS_0596 Interaction Studies:
Proximity-based labeling (BioID or APEX2):
Fuse HS_0596 to a proximity labeling enzyme
Express in native host or relevant model system
Identify labeled proteins by mass spectrometry
Validate top candidates with independent methods
Crosslinking coupled with mass spectrometry:
Apply membrane-permeable crosslinkers to intact cells
Purify HS_0596 complexes under denaturing conditions
Analyze crosslinked peptides by mass spectrometry
Map interaction sites at amino acid resolution
Microscopy-based approaches:
Use split fluorescent proteins to visualize interactions in living cells
Apply super-resolution microscopy to map protein co-localization
Employ single-molecule tracking to analyze dynamic interactions
These approaches incorporate advances in membrane protein research methodology while addressing the specific challenges associated with studying proteins like HS_0596 .
Understanding the structure-function relationship of HS_0596 requires a multi-faceted analytical approach that combines structural characterization with functional assays. The following methods are particularly effective:
Structural Characterization Methods:
Cryo-Electron Microscopy (cryo-EM):
Particularly valuable for membrane proteins that are difficult to crystallize
Can achieve near-atomic resolution structures in native-like environments
Sample preparation involves reconstitution in nanodiscs or vitrification in detergent micelles
X-ray Crystallography:
Requires successful crystallization, which can be challenging for membrane proteins
Lipidic cubic phase (LCP) crystallization may be particularly suitable
Provides high-resolution structural data when successful
Nuclear Magnetic Resonance (NMR) Spectroscopy:
Solution NMR for smaller domains or solid-state NMR for full-length protein
Can provide dynamic information not available from static structures
Useful for mapping interaction sites and conformational changes
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):
Provides information on protein dynamics and solvent accessibility
Useful for identifying regions involved in interactions or conformational changes
Does not require crystallization or isotope labeling
Computational Modeling:
Homology modeling based on related proteins with known structures
Molecular dynamics simulations to study dynamics in membrane environment
Integration with experimental data for model validation
Functional Characterization Methods:
Site-Directed Mutagenesis:
Systematic mutation of key residues identified from structural studies
Functional testing of mutants to identify essential regions
Correlation of structural features with functional outcomes
Domain Mapping:
Expression of isolated domains to identify functional units
Truncation analysis to define minimal functional regions
Chimeric proteins to test domain specificity
Binding and Activity Assays:
Surface plasmon resonance or microscale thermophoresis for binding kinetics
Fluorescence-based assays for monitoring conformational changes
Cell-based assays to assess biological activity in context
Integrated Approach:
The most effective strategy integrates structural and functional data through an iterative process:
Initial computational modeling to predict structure
Low-resolution experimental structural characterization
Identification of potential functional regions
Mutational analysis and functional testing
Refinement of structural models based on functional data
Higher-resolution structural studies focused on key regions
This approach leverages the complementary strengths of different analytical methods to build a comprehensive understanding of HS_0596 structure-function relationships .
Based on current knowledge of H. somni pathogenesis and the properties of HS_0596, several research directions show particular promise:
These research directions build on current understanding of H. somni pathogenesis while focusing specifically on elucidating the role of HS_0596 .
Comparative studies between HS_0596 and related proteins can significantly enhance research approaches and generate new hypotheses. Key aspects of such comparative studies include:
Evolutionary Conservation Analysis:
Identify highly conserved regions that may indicate functional importance
Map sequence conservation onto structural models to identify surface-exposed conserved patches
Compare conservation patterns between pathogenic and non-pathogenic species
Functional Conservation Testing:
Determine if homologs from different species can complement HS_0596 knockout phenotypes
Identify species-specific functional adaptations
Correlate sequence differences with host specificity or virulence capabilities
Structural Comparison Approaches:
Leverage existing structural data from better-characterized homologs
Use homology modeling to predict HS_0596 structure based on solved structures
Identify structural motifs associated with specific functions
Comparative Genomic Context:
Analyze gene neighborhood conservation across species
Identify co-evolved gene clusters that may participate in common pathways
Map operon structures to infer functional relationships
Host-Interaction Comparative Studies:
Compare binding specificities to host factors across species
Investigate whether related proteins target similar host pathways
Identify species-specific adaptations to different host environments
The UPF0283 protein family, to which HS_0596 belongs, is found in various bacterial species, and related transmembrane proteins like TMEM14A in humans show sequence similarity . Comparing HS_0596 with these proteins can provide insights into both conserved functions and pathogen-specific adaptations.
This comparative approach can be particularly valuable given the limited direct information about HS_0596, allowing researchers to leverage findings from better-characterized homologs .
Several emerging technologies show particular promise for advancing research on bacterial membrane proteins like HS_0596:
Cryo-Electron Tomography (cryo-ET):
Enables visualization of membrane proteins in their native cellular context
Can be combined with subtomogram averaging for structural determination
Particularly valuable for studying protein complexes in intact bacterial membranes
Single-Particle cryo-EM with Enhanced Detectors:
Next-generation detectors improve resolution for smaller membrane proteins
New sample preparation techniques reduce preferred orientation issues
Could enable atomic-resolution structures of HS_0596 without crystallization
Integrative Structural Biology Approaches:
Combining multiple experimental datasets (cryo-EM, crosslinking-MS, HDX-MS)
Computational integration to generate comprehensive structural models
Particularly powerful for dynamic or flexible membrane proteins
Advanced Mass Spectrometry Techniques:
Native MS for intact membrane protein complexes
Ion mobility MS for conformational analysis
Targeted proteomics for quantification in complex samples
Artificial Intelligence and Machine Learning:
Improved structure prediction (building on AlphaFold2 advances)
Automated image analysis for cryo-EM data
Prediction of protein-protein interactions and functional sites
Genome Editing Technologies:
CRISPR-Cas systems optimized for bacterial pathogens
Precise genome editing for structure-function studies
High-throughput mutagenesis coupled with functional screening
Advanced Imaging Technologies:
Super-resolution microscopy for protein localization studies
Live-cell imaging with minimal tags
Correlative light and electron microscopy for integrating functional and structural data
Microfluidics and Organ-on-a-Chip:
Controlled host-pathogen interaction studies
Real-time monitoring of infection processes
Testing of multiple conditions with minimal sample requirements
These emerging technologies can address current limitations in membrane protein research and provide new insights into the structure, function, and biological role of HS_0596 and related proteins .